Atrial fibrillation - irregular heart rhythm - affects around 1.4 million UK people.
The safe storage of nuclear waste is a major environmental challenge as spent fuel from fission reactors remains radioactive for hundreds of thousands of years. Professor Kostya Trachenko has made a crucial contribution in this field.
This project has sequenced 100,000 genomes from around 85,000 patients affected by rare disorders and cancers – making the UK a world leader in genomic medicine.
Professor Julia Hörnle and her team explored the risks of online gambling, including addiction, minors playing, indebtedness, fraud, money-laundering and manipulation of sports.
Researchers at Queen Mary have developed an easy-to-use urine test to detect pancreatic cancer. This, in combination with an algorithm-based risk score, may offer earlier detection of the cancer, and offer a significantly better prognosis.
This remarkable project sequences 100,000 genomes from circa 85,000 patients affected by rare disorders and cancers – making the UK a world leader in genomic medicine.
Innovation is driven by new perspectives. We’re pioneering agile, challenge-driven research spaces where experts have the freedom to reimagine what’s possible.
Connect with Queen Mary’s world-leading experts, offering insights and expertise across a wide range of research fields.
At Queen Mary we work with businesses, the public sector and charities around the world to shape policy, drive innovation, and create tangible impact.